Great overview of #palliativecare referral in oncology - When to Refer Patients to Palliative Care: Considerations for the Sustainable Practice of Patient-Centered Supportive Care in Oncology dailynews.ascopubs.org/do/10.1200/ADN… #Pallonc #hapc The ASCO Post @ASCO AAHPM

Amando la vista de hoy 😍 desde el Ins Nal Cancerología

Una de las nuevas iniciativas de #MJO Sociedad Mexicana de Oncología, A.C. para mejorar y ayudar en la publicación de estudios en oncología en México.
GRATIS el curso para escribir artículos médicos del BMJ, inscríbanse ahora!!!
INCMNSZ Ins Nal Cancerología SALUD México

🔊🔊🔊 If a patient with #breastcancer and a BRCA1 (or BRCA2) genetic mutation solicits breast-conserving surgery (BCS), your answer is:

pN1 is the limit of nodal burden to apply RxPONDER criteria and omit chemotherapy in HR+HER2- #breastcancer but…

in cN0 disease with upfront #surgery , how many pN2/pN3 patients are really out there?

2.5 años de pandemia, en plena 5ta 🌊 de COVID-19. Mismas cosas, por si acaso, repasamos. Abro 🧵. 1. La causa de la COVID-19 es el virus 🦠 del SARS-CoV-2. El frío y los aires acondicionados no lo causan

The results of the ESMO elections are out‼️
Congratulations to FabriceAndre for being elected ESMO President for 2025-2026 and to three amazing new ESMO Directors 2023-2024!
Evandro de Azambuja Jean-Yves Blay

congrats! great team! ⁦ESMO - Eur. Oncology⁩

After 4 reviews, many tears, and the fear of sharing my story.

'My White Coat Doesn't Fit' was just published as an Journal of Clinical Oncology Art of Oncology Article.

Article here: ascopubs.org/doi/full/10.12…

This year, we are offering 100 travel grants for young colleagues to attend MAP conference in Amsterdam. MAP is a leading international conference on precision medicine and a unique opportunity to meet international experts on translational research

Very happy and honored to be the new Chair of the Latin American Council of ASCO. Too many exciting projects for the region!!!! #ASCO22 ASCO INCMNSZ HEM ONC INCMNSZ Julie Gralow

How a failed clinical trial led to an important discovery, in nature
PI3K delta inh ↘️ T reg infiltration in tumor (1), particularly an ST2-like T cell pop (pop 8 in 2). T reg ↘️ induces colitis. Intermittent schedule ↗️ results.
rdcu.be/cOuLD

The impact of radiological assessment schedules on progression-free survival in metastatic breast cancer: A systemi… pubmed.ncbi.nlm.nih.gov/34543860/ Intensive response monitoring in RCTs leads to increased magnitude of PFS advantage...This paper is very important IMHO

#ASCO22 abstracts are out!

Honrada y feliz de este logro, nueva vice directora del Departamento de Oncología Torácica de ALAT - Agradezco a quienes siempre han creído en mi y mis locuras ❤️‍🔥❤️‍🔥❤️‍🔥

Your Moment of ✨ work-life Zen ✨
via Dimitrios Tsatiris MD ✨

Do not let work dominate all & “derail family dinners, friendships and free time…”

Important #Leadership to model

cc Gary Lyman 🇺🇸🇪🇺🇺🇦💛💙 Turab J Mohammed, MD Adriana Kahn, MD Jasmine Sukumar MD Maryam Lustberg MD MPH OncoAlert

Presidí la Sesión Extraordinaria del Consejo Directivo Issemym, con su titular Bertha Casado, donde se aprobó el cambio de nomenclatura del Centro Oncológico a Centro Oncológico Estatal “Dr. José Luis Barrera Franco”, en reconocimiento a sus aportaciones en esta especialidad.

This week we received at the LACOG office the visit of Dr. Oscar Arrieta , Head of the Lung Cancer Clinic of the Instituto Nacional de Cancerología de Mexico and member of the LACOG Lung Group. Topics such as the scenario of research in thoracic oncology in LATAM were discussed.